Document is current
Any future updates will be listed below
-
Authors
Schaffer, Leah V. https://orcid.org/0000-0001-6339-9141
Hu, Mengzhou https://orcid.org/0000-0002-1571-8029
Qian, Gege https://orcid.org/0000-0001-5068-0399
Moon, Kyung-Mee https://orcid.org/0000-0003-3796-720X
Pal, Abantika
Soni, Neelesh https://orcid.org/0000-0002-9333-7491
Latham, Andrew P. https://orcid.org/0000-0002-9338-7253
Pontano Vaites, Laura
Tsai, Dorothy https://orcid.org/0000-0002-1484-7961
Mattson, Nicole M.
Licon, Katherine
Bachelder, Robin https://orcid.org/0000-0001-7502-2907
Cesnik, Anthony https://orcid.org/0000-0002-5326-7134
Gaur, Ishan
Le, Trang
Leineweber, William https://orcid.org/0000-0003-3069-398X
Palar, Aji https://orcid.org/0000-0001-9357-6970
Pulido, Ernst https://orcid.org/0000-0002-3616-9743
Qin, Yue
Zhao, Xiaoyu https://orcid.org/0000-0002-6081-2196
Churas, Christopher
Lenkiewicz, Joanna
Chen, Jing
Ono, Keiichiro
Pratt, Dexter https://orcid.org/0000-0002-1471-9513
Zage, Peter
Echeverria, Ignacia
Sali, Andrej https://orcid.org/0000-0003-0435-6197
Harper, J. Wade https://orcid.org/0000-0002-6944-7236
Gygi, Steven P. https://orcid.org/0000-0001-7626-0034
Foster, Leonard J. https://orcid.org/0000-0001-8551-4817
Huttlin, Edward L. https://orcid.org/0000-0002-1822-1173
Lundberg, Emma https://orcid.org/0000-0001-7034-0850
Ideker, Trey https://orcid.org/0000-0002-1708-8454
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 10 March 2025
First Online: 9 April 2025
Change Date: 29 April 2025
Change Type: Update
Change Details: In the version of the article initially published, the text “Knut and Alice Wallenberg Foundation (2021.0346 E.L.), Göran Gustafsson Foundation (E.L), Stanford Institute for Human-Centered AI and Param Hansa Philanthropies” was missing from the Acknowledgments section and has now been added to the HTML and PDF versions of the article.
Competing interests
: T.I. is a co-founder, advisor and holder of equity for Data4Cure and Serinus Biosciences, and he is an advisor and shareholder for Ideaya BioSciences. The terms of these arrangements have been reviewed and approved by UC San Diego in accordance with its conflict of interest policies. E.L. is an advisor for and has equity interest in Cartography Biosciences, Element Biosciences, Santa Ana Bio, Pixelgen Technologies and Moleculent. The terms of these arrangements have been reviewed and approved by Stanford University in accordance with its conflict of interest policies. The BioPlex project has been supported by Interline Therapeutics and Xaira Therapeutics (S.P.G. and E.L.H.). J.W.H. is a co-founder for Caraway Therapeutics (a subsidiary of Merck) and is a scientific advisory board member for Lyterian Therapeutics. S.P.G. is on the scientific advisory board for Thermo Fisher Scientific, Cell Signaling Technology and Frontier Medicine. E.L.H. is a consultant for Matchpoint Therapeutics, Flagship Ventures and Calico Life Sciences. The other authors declare no competing interests.
